Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.198ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.198ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.198NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.366ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.366ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.366ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.366NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.441ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.441ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.441ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.441NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.416ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.416ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.416ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.416NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.63ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.63NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.263ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.263ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.263ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.263NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.135ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.135ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.135ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.135NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FK.1.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FK.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.219ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.219ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.219ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.219NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used